All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …

Delve into Recursion's unique TechBio approach. Discover how we're revolutionizing AI drug discovery and the biotech industry. Read more about our approach today!

By leveraging Recursion’s vast data universe and machine learning models at every stage of the discovery, design and delivery process, we are able to rapidly validate and accelerate high-potential …

Jun 6, 2025 · Powered by Recursion's NVIDIA supercomputer for its training and validation, this next-generation AI model achieves best-in-class accuracy in jointly modeling complex structures and …

Within Recursion, this process typically requires biologists to delineate biological pathways and establish novel map relationships, followed by chemists optimizing chemical series for the selected targets.

Recursion Pharmaceuticals, Inc.

Nov 20, 2024 · “I believe the combination of the incredible teams and platforms at Exscientia and Recursion position us as the leader of the AI-enabled drug discovery and development space,” said …

May 28, 2025 · That’s why we’ve not only been building massive fit-for-purpose datasets at Recursion, but releasing smaller open source versions of these datasets to accelerate the field. Our most recent, …

Oct 9, 2025 · Sanofi continues to leverage combined Recursion OS 2.0, including phenomics, to identify new program opportunities. Recursion and Sanofi are further advancing and expanding their joint …